Abstract
This paper focuses on the recent development of rule-based methods and their applications to the drug discovery process. For a given target, the path for designing new drugs with a lower attrition rate is based on an effective mining of the huge amount of experimental in vitro and in vivo data which has been collected. These data often come in various formats, from many different areas such as chemistry, biology, pharmacology, toxicity and extraction of the critical information is not an easy task. To guide the multi-objective optimization, we have developed a decision-support system (KEM®), based on the Galois lattices theory and constraint satisfaction programming (CSP). After a brief overview of machine learning applications, we will describe the methodology used in KEM for data mining and prediction. Two examples of applications in the drug discovery area will be discussed.
Keywords: Galois lattices, drug design, multi-objective optimization, structure-activity relationships (SAR), machine learning
Current Computer-Aided Drug Design
Title: Novel Rule-Based Method for Multi-Parametric Multi-Objective Decision Support in Lead Optimization Using KEM
Volume: 4 Issue: 1
Author(s): Mohammad Afshar and Nathalie Jullian
Affiliation:
Keywords: Galois lattices, drug design, multi-objective optimization, structure-activity relationships (SAR), machine learning
Abstract: This paper focuses on the recent development of rule-based methods and their applications to the drug discovery process. For a given target, the path for designing new drugs with a lower attrition rate is based on an effective mining of the huge amount of experimental in vitro and in vivo data which has been collected. These data often come in various formats, from many different areas such as chemistry, biology, pharmacology, toxicity and extraction of the critical information is not an easy task. To guide the multi-objective optimization, we have developed a decision-support system (KEM®), based on the Galois lattices theory and constraint satisfaction programming (CSP). After a brief overview of machine learning applications, we will describe the methodology used in KEM for data mining and prediction. Two examples of applications in the drug discovery area will be discussed.
Export Options
About this article
Cite this article as:
Afshar Mohammad and Jullian Nathalie, Novel Rule-Based Method for Multi-Parametric Multi-Objective Decision Support in Lead Optimization Using KEM, Current Computer-Aided Drug Design 2008; 4 (1) . https://dx.doi.org/10.2174/157340908783769238
DOI https://dx.doi.org/10.2174/157340908783769238 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Myocardial Infarction in Systemic Lupus Erythematosus – the Sex-Specific Risk Profile
Current Pharmaceutical Design The Tumor Necrosis Factor-Derived TIP Peptide: A Potential Anti-Edema Drug
Letters in Drug Design & Discovery Study on the Effect of HPMC on Compression Coated Floating Pulsatile Delivery of Bisoprolol
Current Drug Therapy Alkaptonuria, Ochronosis and Ochronotic Arthropathy in Mainland France and the Reunion Island. A Report of Clinical and Molecular Findings in 29 Patients
Current Rheumatology Reviews Fish and Apoptosis: Studies in Disease and Pharmaceutical Design
Current Pharmaceutical Design Renin Angiotensin System (RAS) and Immune System Profile in Specific Subgroups with COVID-19
Current Medicinal Chemistry COPD Evaluation: Beyond the Airway Obstruction, a Follow Up
Current Respiratory Medicine Reviews MicroRNAs in Arterial Hypertension
Current Topics in Medicinal Chemistry Nutrigenetics of the Postprandial Lipoprotein Metabolism: Evidences From Human Intervention Studies
Current Vascular Pharmacology Smooth Muscle Progenitor Cells: Friend or Foe in Vascular Disease?
Current Stem Cell Research & Therapy Therapeutic Potential of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors for the Treatment of Retinal and Eye Diseases
CNS & Neurological Disorders - Drug Targets Cross-Talk Between Adipose Tissue Health, Myocardial Metabolism and Vascular Function: The Adipose-Myocardial and Adipose-Vascular Axes
Current Pharmaceutical Design Developments in Non-Surgical Therapies for Abdominal Aortic Aneurysm
Current Vascular Pharmacology Myocardial Expression of TNF-α, IL-1β, IL-6, IL-8, IL-10 and MCP-1 After a Single MDMA Dose Administered in a Rat Model
Current Pharmaceutical Biotechnology New Concept of Vascular Calcification and Metabolism
Current Vascular Pharmacology Endoscopic Microscopy Using Optical Coherence Tomography
Current Medical Imaging Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical Findings
CNS & Neurological Disorders - Drug Targets Anti-Inflammatory Activity of Tetracyclines: Applications to Human Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inflammation as Therapeutic Objective in Stroke
Current Pharmaceutical Design Endothelins Role in the Control of the Acute Phase of Trypanosoma cruzi Infection
Mini-Reviews in Medicinal Chemistry